CJC-1295 no DAC Nasal Spray
CJC-1295 No DAC Nasal Spray contains Modified GRF(1-29), a synthetic 29-amino-acid analogue of the active region of growth hormone-releasing hormone (GHRH) that lacks the Drug Affinity Complex (DAC) modification, and is available from Direct SARMs in 15 ml and 30 ml sizes.
TOP SELLER
98.9% purityBatch COA includedStore 2–8°C
Price range: $31.69 through $57.13
Buy more, save more
7.5% offspend $250.00
12.5% offspend $400.00
Spend $250.00 for 7.5% off on qualifying items · Applied automatically at checkout
Researchers who bought CJC-1295 no DAC Nasal Spray also bought
CJC-1295 no DAC Nasal Spray
CJC-1295 No DAC, commonly referred to as Modified GRF(1-29) or Mod GRF 1-29, is a synthetic 29-amino-acid analogue of the biologically active region of growth hormone-releasing hormone (GHRH). The peptide incorporates amino-acid substitutions within the GHRH(1-29) sequence and, unlike CJC-1295 DAC, does not contain the Drug Affinity Complex modification. GHRH analogues of this type have been investigated in experimental research concerning GHRH receptor signalling and endocrine pathways. However, findings reported for the structurally distinct DAC-containing CJC-1295 should not automatically be attributed to CJC-1295 No DAC.
Direct SARMs supplies CJC-1295 No DAC as a pre-mixed aqueous nasal spray format for laboratory and analytical research. The 15 ml format contains 2 mg, while the 30 ml format contains 4 mg. The nasal spray designation describes the physical presentation of the research material and does not establish intranasal bioavailability, biological activity, safety or suitability for administration.
CJC-1295 No DAC Nasal Spray is supplied solely as a laboratory research material and is not intended for human or animal consumption or administration, or for diagnostic, therapeutic, clinical or veterinary use.
Benefits of the nasal spray format
1
The dispensing is pre-measured. Each time the spray mechanism is actuated, it releases a constant volume, which allows for repeatable dispensing when carrying out research procedures.
2
Convenient format. Compact spray bottles are straightforward to store, handle, and transport within an appropriate research environment.
3
Ready to use. Unlike lyophilized peptides, which are provided in vials, nasal spray formulations are in liquid form and do not need to be reconstituted before being handled in the laboratory.
4
Protected storage. The bottle protects the formulation by preventing unnecessary handling and exposure to the environment between research procedures.
5
Simple dispensing. The product can be dispensed easily. With an integrated spraying mechanism, it is not necessary to draw the liquid from a vial, offering a simple way to dispense the formulation during research.
Visit the CJC-1295 No DAC Research Hub ▸
CJC-1295 no DAC is supplied exclusively for laboratory research use. The information on this page is provided for scientific and educational reference and is based on available published research. This product is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease or medical condition. It is intended solely for qualified laboratory research and must be handled in accordance with applicable laboratory safety requirements.
Buy CJC-1295 no DAC Nasal Spray Germany from Direct SARMS.
Additional information
| Size(s) | 15ml and 30ml |
| Amount Per Nasal | 15ml = 2mg | 30ml = 4mg |
| Purity | 98.9% |
| Molecular Formula | C152H252N44O42 |
| Molecular Weight | 3367.9 g/mol |
| Sequence | H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
| Physical Form | Pre-mixed aqueous solution |
General information
Applies to all Direct Sarms research compounds unless noted otherwise on the product.
Storage & handling
Store the nasal spray according to the instructions provided on the product label. Keep the bottle securely closed when not in use and protect it from excessive heat and direct light. Follow any product-specific refrigeration requirements stated on the label.
Shipping & discretion
Fully tracked dispatch with worldwide shipping available. Sent in plain, discreet outer packaging with no product description on the label.
FDA disclosure & intended use
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Research use only — not for human or animal consumption. You must be 18+ and a qualified researcher.
Got a question about this CJC-1295 no DAC compound?
CJC-1295 No DAC Nasal Spray is supplied as a pre-mixed aqueous solution, providing the research peptide in liquid form rather than as a dry or lyophilised material.
Direct SARMs supplies CJC-1295 No DAC Nasal Spray in 15 ml and 30 ml formats. The 15 ml format contains 2 mg, while the 30 ml format contains 4 mg of the peptide.
CJC-1295 No DAC is commonly used as a commercial name for Modified GRF(1-29) or Mod GRF 1-29, a synthetic 29-amino-acid analogue of the active N-terminal region of growth hormone-releasing hormone (GHRH). It incorporates four amino-acid substitutions relative to native GHRH(1-29).
The No DAC form does not contain the Drug Affinity Complex modification present in CJC-1295 DAC. The two materials are therefore structurally distinct and should not be treated as interchangeable when reviewing analytical data or published research.
Certificate of Analysis
| Identity | CJC-1295 no DAC | CONFORMS |
| Purity (HPLC) | 98.9% | CONFORMS |
| Mass (LC-MS) | 3367.9 g/mol | CONFORMS |
| Appearance | Pre-mixed aqueous solution | CONFORMS |
